{"id":4704,"date":"2022-02-24T02:15:05","date_gmt":"2022-02-24T02:15:05","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=4704"},"modified":"2023-08-29T17:53:06","modified_gmt":"2023-08-29T17:53:06","slug":"argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=4704","title":{"rendered":"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65"},"content":{"rendered":"<p>Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002<\/p>\n<p>\u8fd9\u4e9b\u7814\u7a76\u4e3aARG-007\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u63d0\u4f9b\u4e86\u5173\u952e\u6570\u636e\uff0c\u4e3a\u5373\u5c06\u8fdb\u884c\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u652f\u6301\u3002<\/p>\n<p>Argenica\u4e0eMedicilon\u516c\u53f8\u5408\u4f5c\uff0c\u5bf9ARG-007\u8fdb\u884c\u4e86\u4e24\u9879\u4f53\u5916\u9057\u4f20\u6bd2\u6027\u7814\u7a76\u3002<\/p>\n<p>\u636eArgenica\u62a5\u9053\uff0c\u7814\u7a76\u6570\u636e\u663e\u793aARG-007\u201c\u4e0d\u4f1a\u5bf9\u60a3\u8005\u6784\u6210\u9057\u4f20\u6216\u81f4\u764c\u98ce\u9669\u201d\u3002\u5b83\u4e5f\u4e0d\u4f1a\u5bf9\u54fa\u4e73\u52a8\u7269\u7ec6\u80de\u7684\u67d3\u8272\u4f53\u9020\u6210\u4efb\u4f55\u7ed3\u6784\u635f\u4f24\u3002<\/p>\n<p>\u201c\u8fd9\u4e9bGLP\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u7684\u7ed3\u679c\u5bf9\u5305\u5bb9\u5f88\u91cd\u8981\u5728\u6211\u4eec\u7684\u9053\u5fb7\u63d0\u4ea4\u5f00\u59cb\u6211\u4eec\u7684\u7b2c\u4e00\u9636\u6bb5\u7684\u4e34\u5e8a\u8bd5\u9a8c\u2014\u2014\u663e\u7136\u8bc1\u660e\u5fd7\u613f\u8005\u7ba1\u7406\u53c2\u6570\u2014\u2014007\u5e74\u5c06\u6ca1\u6709\u5f71\u54cd\u4ed6\u4eec\u7684DNA\u6216\u67d3\u8272\u4f53\u6216\u4ee5\u4efb\u4f55\u65b9\u5f0f\u5f15\u8d77\u764c\u75c7,\u201d\u9996\u5e2d\u6267\u884c\u5b98Argenica Liz Dallimore\u535a\u58eb\u89e3\u91ca\u9053\u3002<\/p>\n<p>\u201c\u6b64\u5916\uff0cGLP\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u9700\u8981\u83b7\u5f97\u7f8e\u56fdFDA\u5bf9ARG-007\u7684\u6279\u51c6\uff0c\u56e0\u6b64\u5b83\u4e3a\u6211\u4eec\u63a8\u8fdbARG-007\u7684\u4e34\u5e8a\u5f00\u53d1\u63d0\u4f9b\u4e86\u66f4\u591a\u7684\u4fe1\u5fc3\u3002\u201d<\/p>\n<h2>\u63a8\u8fdbARG-007<\/h2>\n<p>\u57fa\u56e0\u6bd2\u6027\u6570\u636e\u5c06\u5305\u62ec\u5728\u4f26\u7406\u63d0\u4ea4\u4e2d\uff0c\u4ee5\u786e\u4fdd\u8bd5\u9a8c\u83b7\u5f97\u6279\u51c6\u3002\u8fd9\u4e9b\u7814\u7a76\u4e5f\u662fFDA\u6279\u51c6\u7684\u5b9e\u9a8c\u6027\u65b0\u836f\uff0c\u8fd9\u610f\u5473\u7740\u76d1\u7ba1\u673a\u6784\u5c06\u9700\u8981\u8fd9\u4e9b\u4fe1\u606f\uff0c\u4ee5\u4fbf\u5728\u7f8e\u56fd\u8fdb\u884c\u540e\u671f\u4e34\u5e8a\u7814\u7a76\u3002<\/p>\n<p>\u5728\u542f\u52a8\u4e34\u5e8a\u7814\u7a76\u4e4b\u524d\uff0cArgenica\u7684\u4e0b\u4e00\u6b65\u662f\u786e\u5b9aGLP\u836f\u4ee3\u52a8\u529b\u5b66(PK)\u548c\u6bd2\u7406\u5b66\u7814\u7a76\u7684\u5242\u91cf\uff0c\u8fd9\u5df2\u7ecf\u5f00\u59cb\u3002<\/p>\n<p>\u8fd9\u4e9b\u4e34\u5e8a\u524d\u6d3b\u52a8\u7684\u6570\u636e\u9884\u8ba1\u5c06\u5728\u672c\u5b63\u5ea6\u548c6\u6708\u7684\u5b63\u5ea6\u521d\u8fdb\u884c\u3002<\/p>\n<p>\u8fd9\u4e00\u4fe1\u606f\u4e5f\u9700\u8981\u5728\u5065\u5eb7\u4eba\u7c7b\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\u76841\u671f\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\u3002<\/p>\n<p>\u4e3a\u4e86\u52a0\u5feb\u4f26\u7406\u5ba1\u6279\uff0cArgenica\u5df2\u7ecf\u5b8c\u6210\u4e86\u63d0\u4ea4\u7684\u8349\u6848\uff0c\u5c06\u7531Bellberry\u5ba1\u67e5\uff0c\u8be5\u7ec4\u7ec7\u5c06\u901a\u8fc7\u5176\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u63d0\u4f9b\u6700\u7ec8\u6279\u51c6\u3002<\/p>\n<p>\u5ba1\u67e5\u5b8c\u8349\u6848\u63d0\u4ea4\u540e\uff0cBellberry\u5c06\u63d0\u4f9b\u53cd\u9988\u3002\u4e00\u65e6\u638c\u63e1\u4e86\u6240\u6709\u6240\u9700\u7684\u6570\u636e\uff0cArgenica\u5c06\u7acb\u5373\u63d0\u4ea4\u6700\u7ec8\u7684\u4f26\u7406\u7533\u8bf7\uff0c\u9884\u8ba1\u5c06\u4e8e\u4e0b\u4e2a\u5b63\u5ea6\u5b8c\u6210\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002 \u8fd9\u4e9b\u7814\u7a76\u4e3aARG-007\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u63d0\u4f9b\u4e86\u5173\u952e\u6570\u636e\uff0c\u4e3a\u5373\u5c06\u8fdb\u884c\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u652f\u6301\u3002 Argenica\u4e0eMedicilon\u516c\u53f8\u5408\u4f5c\uff0c\u5bf9ARG-007\u8fdb\u884c\u4e86\u4e24\u9879\u4f53\u5916\u9057\u4f20\u6bd2\u6027\u7814\u7a76\u3002 \u636eArgenica\u62a5\u9053\uff0c\u7814\u7a76\u6570\u636e\u663e\u793aARG-007\u201c\u4e0d\u4f1a\u5bf9\u60a3\u8005\u6784\u6210\u9057\u4f20\u6216\u81f4\u764c\u98ce\u9669\u201d\u3002\u5b83\u4e5f\u4e0d\u4f1a\u5bf9\u54fa\u4e73\u52a8\u7269\u7ec6\u80de\u7684\u67d3\u8272\u4f53\u9020\u6210\u4efb\u4f55\u7ed3\u6784\u635f\u4f24\u3002 \u201c\u8fd9\u4e9bGLP\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u7684\u7ed3\u679c\u5bf9\u5305\u5bb9\u5f88\u91cd\u8981\u5728\u6211\u4eec\u7684\u9053\u5fb7\u63d0\u4ea4\u5f00\u59cb\u6211\u4eec\u7684\u7b2c\u4e00\u9636\u6bb5\u7684\u4e34\u5e8a\u8bd5\u9a8c\u2014\u2014\u663e\u7136\u8bc1\u660e\u5fd7\u613f\u8005\u7ba1\u7406\u53c2\u6570\u2014\u2014007\u5e74\u5c06\u6ca1\u6709\u5f71\u54cd\u4ed6\u4eec\u7684DNA\u6216\u67d3\u8272\u4f53\u6216\u4ee5\u4efb\u4f55\u65b9\u5f0f\u5f15\u8d77\u764c\u75c7,\u201d\u9996\u5e2d\u6267\u884c\u5b98Argenica Liz Dallimore\u535a\u58eb\u89e3\u91ca\u9053\u3002 \u201c\u6b64\u5916\uff0cGLP\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u9700\u8981\u83b7\u5f97\u7f8e\u56fdFDA\u5bf9ARG-007\u7684\u6279\u51c6\uff0c\u56e0\u6b64\u5b83\u4e3a\u6211\u4eec\u63a8\u8fdbARG-007\u7684\u4e34\u5e8a\u5f00\u53d1\u63d0\u4f9b\u4e86\u66f4\u591a\u7684\u4fe1\u5fc3\u3002\u201d \u63a8\u8fdbARG-007 \u57fa\u56e0\u6bd2\u6027\u6570\u636e\u5c06\u5305\u62ec\u5728\u4f26\u7406\u63d0\u4ea4\u4e2d\uff0c\u4ee5\u786e\u4fdd\u8bd5\u9a8c\u83b7\u5f97\u6279\u51c6\u3002\u8fd9\u4e9b\u7814\u7a76\u4e5f\u662fFDA\u6279\u51c6\u7684\u5b9e\u9a8c\u6027\u65b0\u836f\uff0c\u8fd9\u610f\u5473\u7740\u76d1\u7ba1\u673a\u6784\u5c06\u9700\u8981\u8fd9\u4e9b\u4fe1\u606f\uff0c\u4ee5\u4fbf\u5728\u7f8e\u56fd\u8fdb\u884c\u540e\u671f\u4e34\u5e8a\u7814\u7a76\u3002 \u5728\u542f\u52a8\u4e34\u5e8a\u7814\u7a76\u4e4b\u524d\uff0cArgenica\u7684\u4e0b\u4e00\u6b65\u662f\u786e\u5b9aGLP\u836f\u4ee3\u52a8\u529b\u5b66(PK)\u548c\u6bd2\u7406\u5b66\u7814\u7a76\u7684\u5242\u91cf\uff0c\u8fd9\u5df2\u7ecf\u5f00\u59cb\u3002 \u8fd9\u4e9b\u4e34\u5e8a\u524d\u6d3b\u52a8\u7684\u6570\u636e\u9884\u8ba1\u5c06\u5728\u672c\u5b63\u5ea6\u548c6\u6708\u7684\u5b63\u5ea6\u521d\u8fdb\u884c\u3002 \u8fd9\u4e00\u4fe1\u606f\u4e5f\u9700\u8981\u5728\u5065\u5eb7\u4eba\u7c7b\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\u76841\u671f\u8bd5\u9a8c\u7684\u4f26\u7406\u6279\u51c6\u3002 \u4e3a\u4e86\u52a0\u5feb\u4f26\u7406\u5ba1\u6279\uff0cArgenica\u5df2\u7ecf\u5b8c\u6210\u4e86\u63d0\u4ea4\u7684\u8349\u6848\uff0c\u5c06\u7531Bellberry\u5ba1\u67e5\uff0c\u8be5\u7ec4\u7ec7\u5c06\u901a\u8fc7\u5176\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u63d0\u4f9b\u6700\u7ec8\u6279\u51c6\u3002 \u5ba1\u67e5\u5b8c\u8349\u6848\u63d0\u4ea4\u540e\uff0cBellberry\u5c06\u63d0\u4f9b\u53cd\u9988\u3002\u4e00\u65e6\u638c\u63e1\u4e86\u6240\u6709\u6240\u9700\u7684\u6570\u636e\uff0cArgenica\u5c06\u7acb\u5373\u63d0\u4ea4\u6700\u7ec8\u7684\u4f26\u7406\u7533\u8bf7\uff0c\u9884\u8ba1\u5c06\u4e8e\u4e0b\u4e2a\u5b63\u5ea6\u5b8c\u6210\u3002<\/p>\n","protected":false},"author":3,"featured_media":18296,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[888],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65<\/title>\n<meta name=\"description\" content=\"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65\" \/>\n<meta property=\"og:description\" content=\"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-24T02:15:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:53:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Good-Laboratory-Practice-GLP-genotoxicity-studies-ARG-007-brain-genetic-DNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/\",\"name\":\"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-02-24T02:15:05+00:00\",\"dateModified\":\"2023-08-29T17:53:06+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65","description":"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65","og_description":"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/","og_site_name":"smallcapsCN","article_published_time":"2022-02-24T02:15:05+00:00","article_modified_time":"2023-08-29T17:53:06+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Good-Laboratory-Practice-GLP-genotoxicity-studies-ARG-007-brain-genetic-DNA.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/","url":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/","name":"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-02-24T02:15:05+00:00","dateModified":"2023-08-29T17:53:06+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Argenica Therapeutics (ASX: AGN)\u7684\u4e2d\u98ce\u6cbb\u7597\u5148\u5bfc\u836f\u7269ARG-007\u5373\u5c06\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e0e\u516c\u53f8\u5b8c\u6210\u6700\u7ec8\u7684\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303(GLP)\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/argenica-therapeutics-moves-closer-clinical-trials-genotoxicity-studies-arg-007\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Argenica Therapeutics\u5b8c\u6210ARG-007\u57fa\u56e0\u6bd2\u6027\u7814\u7a76\u540e\uff0c\u79bb\u4e34\u5e8a\u8bd5\u9a8c\u66f4\u8fd1\u4e86\u4e00\u6b65"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4704"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4704"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4704\/revisions"}],"predecessor-version":[{"id":14583,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4704\/revisions\/14583"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18296"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}